Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer | |
Hu, Xichun; Cao, Jun; Hu, Wenwei; Wu, Changping; Pan, Yueyin; Cai, Li; Tong, Zhongsheng; Wang, Shusen; Li, Jin; Wang, Zhonghua | |
刊名 | BMC CANCER |
2014 | |
卷号 | 14 |
关键词 | Apatinib Metastatic breast cancer VEGF |
ISSN号 | 1471-2407 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4878117 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Hu, Xichun,Cao, Jun,Hu, Wenwei,et al. Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer[J]. BMC CANCER,2014,14. |
APA | Hu, Xichun.,Cao, Jun.,Hu, Wenwei.,Wu, Changping.,Pan, Yueyin.,...&Yu, Hao.(2014).Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer.BMC CANCER,14. |
MLA | Hu, Xichun,et al."Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer".BMC CANCER 14(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论